← Back to all trials
Not Yet Recruiting
NCT05721742
Evaluating the Impact of Including Virtual Dietary Education Within an Electronic Irritable Bowel Syndrome Pathway
Conditions: IBS - Irritable Bowel Syndrome
Sex: All
Ages: 18 Years – 65 Years
Phase: NA
Enrollment: 76
Sponsor: Nova Scotia Health Authority
Summary
Irritable bowel syndrome is a functional bowel disorder that affects many Canadians.
The syndrome involves abdominal pain and change in frequency or form of bowel movements, and these symptoms can lead to a decreased quality of life for patients.
Primary care physicians are dissatisfied with current referral processes, and patients may wait a long time to receive the correct diagnosis.
Diet is known to exacerbate symptoms of IBS.
In Canada, accessing dietary treatment for IBS is a challenge due to lack of resources.
Some patients lack access to dietary interventions, and others are given advice that is not evidenced based.
Use of eHealth technology, such as virtual education delivered by a dietician, may allow for more widespread access to dietary interventions for IBS.
Virtual education can include one on one dietary education, online group-based education, and the use of apps.
Currently, there is a gap in knowledge whether dietary intervention for IBS, delivered virtually by a dietician, is effective in treating IBS.
Eligibility Criteria
Inclusion Criteria:Recurrent abdominal pain on average at least 1 day/ week in the last 3 months associated with two or more of the following criteria: related to defecation, or association with a change in frequency of stool or associated with a change in form (appearance) of stoolWillingness to change dietAccess to a device for accessing virtual dietary educationExclusion Criteria:New onset symptoms within past year in age 50 and aboveRectal bleedingInflammatory Bowel DiseaseUnexplained recent weight lossGastrointestinal surgery with removal of gallbladder or segments of the bowelHaving an eating disorder
Source: ClinicalTrials.gov (NCT05721742). StuddyBuddy aggregates publicly available trial information.